187 related articles for article (PubMed ID: 24096150)
1. Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.
Hayden RS; Vollrath M; Kaplan DL
Acta Biomater; 2014 Jan; 10(1):486-93. PubMed ID: 24096150
[TBL] [Abstract][Full Text] [Related]
2. Quantitative characterization of mineralized silk film remodeling during long-term osteoblast-osteoclast co-culture.
Hayden RS; Quinn KP; Alonzo CA; Georgakoudi I; Kaplan DL
Biomaterials; 2014 Apr; 35(12):3794-802. PubMed ID: 24484674
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
Frith JC; Rogers MJ
J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
[TBL] [Abstract][Full Text] [Related]
5. The effect of alendronate doped calcium phosphates on bone cells activity.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156
[TBL] [Abstract][Full Text] [Related]
6. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.
Wang Y; Panasiuk A; Grainger DW
Mol Pharm; 2011 Aug; 8(4):1016-24. PubMed ID: 21186792
[TBL] [Abstract][Full Text] [Related]
9. RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.
Sutherland KA; Rogers HL; Tosh D; Rogers MJ
Arthritis Res Ther; 2009; 11(2):R58. PubMed ID: 19405951
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast: osteoclast co-cultures on silk fibroin, chitosan and PLLA films.
Jones GL; Motta A; Marshall MJ; El Haj AJ; Cartmell SH
Biomaterials; 2009 Oct; 30(29):5376-84. PubMed ID: 19647869
[TBL] [Abstract][Full Text] [Related]
11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast-osteoclast-endothelial cell co-culture study.
Forte L; Torricelli P; Boanini E; Gazzano M; Rubini K; Fini M; Bigi A
Acta Biomater; 2016 Mar; 32():298-308. PubMed ID: 26689470
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast-osteoclast co-culture study.
Dolci LS; Panzavolta S; Torricelli P; Albertini B; Sicuro L; Fini M; Bigi A; Passerini N
Int J Pharm; 2019 Jan; 554():245-255. PubMed ID: 30423416
[TBL] [Abstract][Full Text] [Related]
14. Indirect osteoblast differentiation by liposomal clodronate.
Okada E; Nakata H; Yamamoto M; Kasugai S; Kuroda S
J Cell Mol Med; 2018 Feb; 22(2):1127-1137. PubMed ID: 29063674
[TBL] [Abstract][Full Text] [Related]
15. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
[TBL] [Abstract][Full Text] [Related]
16. Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage.
Forte L; Torricelli P; Boanini E; Rubini K; Fini M; Bigi A
J Biomed Mater Res A; 2017 Dec; 105(12):3293-3303. PubMed ID: 28865182
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.
Kim SE; Suh DH; Yun YP; Lee JY; Park K; Chung JY; Lee DW
J Mater Sci Mater Med; 2012 Nov; 23(11):2739-49. PubMed ID: 22850978
[TBL] [Abstract][Full Text] [Related]
18. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells.
Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A
Biomaterials; 2008 Mar; 29(7):790-6. PubMed ID: 18022226
[TBL] [Abstract][Full Text] [Related]
19. Concentration-dependent effects of alendronate and pamidronate functionalized gold nanoparticles on osteoclast and osteoblast viability.
Conners CM; Bhethanabotla VR; Gupta VK
J Biomed Mater Res B Appl Biomater; 2017 Jan; 105(1):21-29. PubMed ID: 26372402
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates: preclinical aspects and use in osteoporosis.
Fleisch HA
Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
